24.50

3.15% -0.85

10 X Genomics Inc (TXG)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Precedente Chiudi:

$25.35

Aprire:

$25.36

Volume 24 ore:

376.08K

Relative Volume:

0.15

Capitalizzazione di mercato:

$3.13B

Reddito:

$642.82M

Utile/perdita netta:

$-43.54M

Rapporto P/E:

-70.08

EPS:

-0.3496

Flusso di cassa netto:

$130.12M

1 W Prestazione:

+6.74%

1M Prestazione:

+47.10%

6M Prestazione:

+98.31%

1 anno Prestazione:

+205.74%

Intervallo 1D:

$24.29

$25.57

Intervallo di 1 settimana:

$22.56

$25.69

Portata 52W:

$7.25

$25.69

10 X Genomics Inc Stock (TXG) Company Profile

Nome

10 X Genomics Inc

Settore

Healthcare (1116)

Industria

Health Information Services (51)

Telefono

(925) 401-7300

Indirizzo

6230 STONERIDGE MALL ROAD, PLEASANTON, CA

Dipendente

1,178

Cinguettio

@10xgenomics

Prossima data di guadagno

2024-10-31

Ultimi documenti SEC

TXG's Discussions on Twitter

Compare TXG vs VEEV, TEM, BTSG, HQY, WAY

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
TXG 10 X Genomics Inc	24.53	3.24B	642.82M	-43.54M	130.12M	-0.3496
VEEV Veeva Systems Inc	169.83	27.33B	3.20B	908.91M	1.39B	5.4168
TEM Tempus Ai Inc	53.52	10.12B	1.27B	-245.03M	-245.36M	-1.4071
BTSG Brightspring Health Services Inc	45.97	8.89B	12.91B	104.80M	394.69M	0.8769
HQY Healthequity Inc	83.96	7.07B	1.31B	215.20M	408.32M	2.4627
WAY Waystar Holding Corp	25.51	4.73B	1.10B	112.09M	283.19M	0.6096

10 X Genomics Inc Stock (TXG) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2026-03-31	Aggiornamento	William Blair	Mkt Perform → Outperform
2025-12-11	Downgrade	Citigroup	Buy → Neutral
2025-12-02	Downgrade	Morgan Stanley	Overweight → Equal-Weight
2025-09-11	Iniziato	Piper Sandler	Neutral
2025-02-13	Downgrade	Leerink Partners	Outperform → Market Perform
2024-09-03	Iniziato	Leerink Partners	Outperform
2024-07-22	Aggiornamento	Jefferies	Hold → Buy
2024-07-18	Downgrade	JP Morgan	Overweight → Neutral
2024-07-10	Downgrade	Deutsche Bank	Buy → Hold
2024-06-27	Downgrade	Wolfe Research	Outperform → Peer Perform
2024-06-25	Downgrade	Guggenheim	Buy → Neutral
2024-06-03	Ripresa	Jefferies	Hold
2024-05-01	Downgrade	TD Cowen	Buy → Hold
2023-12-14	Iniziato	Guggenheim	Buy
2023-12-13	Iniziato	Wolfe Research	Outperform
2023-12-12	Aggiornamento	BofA Securities	Underperform → Neutral
2023-07-05	Ripresa	JP Morgan	Overweight
2023-05-10	Iniziato	Barclays	Overweight
2023-03-31	Iniziato	Stephens	Overweight
2023-02-02	Iniziato	UBS	Neutral
2022-12-14	Iniziato	Deutsche Bank	Buy
2022-08-18	Downgrade	Goldman	Neutral → Sell
2022-07-25	Iniziato	Canaccord Genuity	Buy
2022-07-15	Downgrade	BofA Securities	Neutral → Underperform
2022-07-15	Downgrade	William Blair	Outperform → Mkt Perform
2021-10-15	Ripresa	Cowen	Outperform
2021-09-14	Downgrade	BofA Securities	Buy → Neutral
2021-03-15	Iniziato	William Blair	Outperform
2020-12-02	Iniziato	Goldman	Neutral
2020-09-09	Iniziato	Morgan Stanley	Overweight
2020-07-10	Iniziato	Stifel	Buy
2020-03-05	Iniziato	Guggenheim	Buy
2020-01-07	Iniziato	Citigroup	Buy
2019-10-07	Iniziato	BofA/Merrill	Buy
2019-10-07	Iniziato	Cowen	Outperform
2019-10-07	Iniziato	JP Morgan	Overweight
2019-09-24	Iniziato	Evercore ISI	Outperform

Mostra tutto

10 X Genomics Inc Borsa (TXG) Ultime notizie

Apr 15, 2026

10x Genomics to Report First Quarter 2026 Financial Results on May 7, 2026 - Moomoo

Apr 15, 2026

10x Genomics $TXG Stake Boosted by Tudor Investment Corp ET AL - MarketBeat

Apr 15, 2026

Apr 14, 2026

10x Genomics Is Maintained at Overweight by Barclays - Moomoo

Apr 14, 2026

Is It Too Late To Consider 10x Genomics (TXG) After Its 185% One-Year Surge? - simplywall.st

Apr 14, 2026

10x Genomics $TXG Shares Bought by Sumitomo Mitsui Trust Group Inc. - MarketBeat

Apr 14, 2026

Apr 13, 2026

10X Genomics Opens with 6.32% Gain, Outperforming S&P 500's 2.51% Increase - Markets Mojo

Apr 13, 2026

TXG Stock Chart | 10X GENOMICS INC-CLASS A (NASDAQ:TXG) - ChartMill

Apr 13, 2026

Apr 12, 2026

Best Genetic Sequencing Stocks for 2026 and How to Invest in Them - The Motley Fool

Apr 12, 2026

Apr 10, 2026

TXG (10x Genomics) Receipts from Customers - GuruFocus

Apr 10, 2026

TXG (10x Genomics) Short-term investments - GuruFocus

Apr 10, 2026

Global Next-Generation Sequencing (NGS) Market to Double in Size by 2030 - GlobeNewswire Inc.

Apr 10, 2026

10X Genomics Hits New 52-Week High of $23.60, Reflecting Strong Growth - Markets Mojo

Apr 10, 2026

Apr 08, 2026

10x Genomics stock hits 52-week high at 23.6 USD By Investing.com - Investing.com Canada

Apr 08, 2026